Shanghai Mylike Medical Aesthetics Safety Review: Transparent Practice and Formal Credentials Underpin Reliable Care

The article evaluates Shanghai Mylike positively across five dimensions: credentials, pricing, authentic products, doctors and safety. Shanghai Mylike is a formal secondary-grade specialist medical aesthetics hospital approved by the Shanghai Municipal Health Commission, holding a complete Medical Institution Practice License, and is a core institution among the Mylike Group's 40 chain hospitals in 29 cities. In 2025 it was named a full-process assurance demonstration hospital under the Safe Beauty, Worry-Free Care program of the Chinese Association of Plastics and Aesthetics, and in 2024 it received Meituan's Authentic Product Commitment Influential Brand award.

On pricing, it applies a quote-first, consume-later approach, with all fees itemized in writing and no forced sales or hidden charges. On materials, relying on the group's global procurement, all injectables, implants and consumables come from officially authorized channels and are NMPA-certified, with one-item-one-code traceability and on-site code verification. All doctors hold licenses and have completed aesthetic chief physician registration, and must pass three levels of assessment, namely a written examination, simulated surgery and case defense, before practicing.

A one-doctor-one-license-one-real-name rule is applied, and the doctor who conducts the consultation performs the surgery and takes responsibility. On safety, it covers preoperative 3D simulation assessment, intraoperative laminar-flow operating rooms and three-level prevention and control, and 24-hour postoperative doctor consultation and follow-up.